In a recent New England Journal of Medicine commentary, a group of experts including the Bixby Center’s Dr. Daniel Grossman called on the FDA to eliminate the FDA's excessive regulation of the medication abortion drug mifepristone.
A group of experts, including Daniel Grossman, MD, director of ANSIRH and Bixby Center member, calls for an end to the FDA's overregulation of Mifeprex (mifepristone), a drug commonly used in medication abortions.
A new study, conducted by ANSIRH, finds that portrayals of abortion on TV make them seem much easier to get than they actually are, contributing to an overall lack of understanding about the realities of getting one.
A new analysis of the Turnaway Study provides an unprecedented look at how women denied abortion weigh adoption as an alternative. Opponents of abortion often portray adoption as an equally desirable and viable alternative to abortion, but this study paints a very different picture.
A new study finds that over 90 percent of young women report using at least one strategy to protect themselves from acquiring sexually transmitted infections (STIs). However, the types of strategies used by young women differ along racial/ethnic lines.
Currently, 29 US states require health care providers to use state-approved materials when counseling a woman considering abortion. A new study illustrates how inaccuracies in these state-mandated materials can perpetuate misperceptions about abortion.
In honor of the 44th anniversary of Roe v. Wade, Amy Hagstrom Miller of Whole Woman’s Health spoke to UCSF Bixby Center members and friends last week. Ms. Miller was the lead plaintiff in last year’s Whole Woman’s Health v. Hellerstedt Supreme Court case, which struck down groundless abortion restrictions.